These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 18979180
21. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease. Andrade-Campos M, Alfonso P, Irun P, Armstrong J, Calvo C, Dalmau J, Domingo MR, Barbera JL, Cano H, Fernandez-Galán MA, Franco R, Gracia I, Gracia-Antequera M, Ibañez A, Lendinez F, Madruga M, Martin-Hernández E, O'Callaghan MDM, Del Soto AP, Del Prado YR, Sancho-Val I, Sanjurjo P, Pocovi M, Giraldo P. Orphanet J Rare Dis; 2017 May 03; 12(1):84. PubMed ID: 28468677 [Abstract] [Full Text] [Related]
22. Types I and III Gaucher disease in Poland: incidence of the most common mutations and phenotypic manifestations. Tylki-Szymańska A, Millat G, Maire I, Czartoryska B. Eur J Hum Genet; 1996 May 03; 4(6):334-7. PubMed ID: 9043866 [Abstract] [Full Text] [Related]
23. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3). Weinreb NJ, Finegold DN, Feingold E, Zeng Z, Rosenbloom BE, Shankar SP, Amato D. Orphanet J Rare Dis; 2015 May 22; 10():64. PubMed ID: 25994334 [Abstract] [Full Text] [Related]
24. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, Batista JL, Cox GF, Mistry PK. Mol Genet Metab; 2017 May 22; 120(1-2):47-56. PubMed ID: 28040394 [Abstract] [Full Text] [Related]
25. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Rosenbloom B, Balwani M, Bronstein JM, Kolodny E, Sathe S, Gwosdow AR, Taylor JS, Cole JA, Zimran A, Weinreb NJ. Blood Cells Mol Dis; 2011 Jan 15; 46(1):95-102. PubMed ID: 21067946 [Abstract] [Full Text] [Related]
26. [Gaucher disease: importance of early diagnosis and therapy]. Simon G, Erdos M, Maródi L, Tóth J. Orv Hetil; 2008 Apr 20; 149(16):743-50. PubMed ID: 18426721 [Abstract] [Full Text] [Related]
27. Children with type 1 Gaucher disease: Changing profiles in the 21st century. Elstein D, Altarescu G, Abrahamov A, Zimran A. Blood Cells Mol Dis; 2018 Feb 20; 68():93-96. PubMed ID: 28185830 [Abstract] [Full Text] [Related]
28. Gaucher disease in Syrian children: common mutations identification, and clinical futures. Alasmar D. Ann Saudi Med; 2015 Feb 20; 35(2):127-32. PubMed ID: 26336018 [Abstract] [Full Text] [Related]
29. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Kaplan P, Andersson HC, Kacena KA, Yee JD. Arch Pediatr Adolesc Med; 2006 Jun 20; 160(6):603-8. PubMed ID: 16754822 [Abstract] [Full Text] [Related]
30. [Clinical phenotype and genotype of Gaucher disease in 14 children]. Sun XY, Xue Y, Wang YP, Huang J, Lin RF, Kang MY, Fang YJ. Zhonghua Er Ke Za Zhi; 2022 Jun 02; 60(6):527-532. PubMed ID: 35658357 [Abstract] [Full Text] [Related]
31. Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes. Orenstein M, Barbouth D, Bodamer OA, Weinreb NJ. Orphanet J Rare Dis; 2014 Mar 31; 9():45. PubMed ID: 24685312 [Abstract] [Full Text] [Related]
32. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease. Torralba MA, Pérez-Calvo JI. J Inherit Metab Dis; 2009 Jun 31; 32(3):453-4; author reply 455-6. PubMed ID: 19322674 [No Abstract] [Full Text] [Related]
33. Clinical and molecular characteristics of Japanese Gaucher disease. Eto Y, Ida H. Neurochem Res; 1999 Feb 31; 24(2):207-11. PubMed ID: 9972866 [Abstract] [Full Text] [Related]
34. Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level. Amaral O, Fortuna AM, Lacerda L, Pinto R, Sa Miranda MC. J Med Genet; 1994 May 31; 31(5):401-4. PubMed ID: 8064820 [Abstract] [Full Text] [Related]
35. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease. Beutler E, Beutler L, West C. J Lab Clin Med; 2004 Aug 31; 144(2):65-8. PubMed ID: 15322500 [Abstract] [Full Text] [Related]
37. Divergent phenotypes in Gaucher disease implicate the role of modifiers. Goker-Alpan O, Hruska KS, Orvisky E, Kishnani PS, Stubblefield BK, Schiffmann R, Sidransky E. J Med Genet; 2005 Jun 31; 42(6):e37. PubMed ID: 15937077 [Abstract] [Full Text] [Related]
38. Adult Gaucher disease in southern Tunisia: report of three cases. Ben Rhouma F, Kallel F, Kefi R, Cherif W, Nagara M, Azaiez H, Jedidi I, Elloumi M, Abdelhak S, Mseddi S. Diagn Pathol; 2012 Jan 10; 7():4. PubMed ID: 22233685 [Abstract] [Full Text] [Related]
39. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Khan A, Hangartner T, Weinreb NJ, Taylor JS, Mistry PK. J Bone Miner Res; 2012 Aug 10; 27(8):1839-48. PubMed ID: 22692814 [Abstract] [Full Text] [Related]
40. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays. Mao R, O'Brien JF, Rao S, Schmitt E, Roa B, Feldman GL, Spence WC, Snow K. Mol Genet Metab; 2001 Mar 10; 72(3):248-53. PubMed ID: 11243731 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]